Phase I/II study of first-line irinotecan combined with 5-fluorouracil and folinic acid Mayo Clinic schedule in patients with advanced colorectal cancer

BACKGROUND: This multicentre phase I/II study was designed to determine the maximum tolerated dose of irinotecan when combined with 5-fluorouracil and folinic acid according to the Mayo Clinic schedule and to evaluate the activity of this combination as first-line therapy in patients with advanced c...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Kuehr, Thomas, Ruff, Paul, Rapoport, Bernardo L, Falk, Stephen, Daniel, Francis, Jacobs, Conrad, Davidson, Neville, Thaler, Josef, Boussard, Blandine, Carmichael, James
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2004
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC493270/
https://ncbi.nlm.nih.gov/pubmed/15257756
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-4-36
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы